Ex-Shkreli Employee's Expanded $1.3M Fraud Suit Lives On
Law360 (September 30, 2019, 6:04 PM EDT) -- A Brooklyn federal judge has ruled that a former employee of convicted "pharma bro" fraudster Martin Shkreli at Turing Pharmaceuticals LLC, now Vyera Pharmaceuticals, can move forward with his fraud and contract suit against Shkreli and tack on another five claims, but must jettison his RICO claim.
Edward Painter, onetime director of investor relations for Turing, seeks $1.3 million in his suit alleging that Shkreli forced him to invest $275,000 in the company, but never received stock. Shkreli was convicted in August 2017 of securities fraud and conspiracy and is serving a seven-year sentence.
U.S. Judge Carol Bagley Amon reasoned Friday in a ruling on a motion to dismiss...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!